Colgate-Palmolive (NYSE:CL) Shares Acquired by Ritholtz Wealth Management

Ritholtz Wealth Management grew its position in Colgate-Palmolive (NYSE:CL - Free Report) by 11.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 68,745 shares of the company's stock after purchasing an additional 7,123 shares during the quarter. Ritholtz Wealth Management's holdings in Colgate-Palmolive were worth $6,250,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive during the 3rd quarter worth $42,000. Capital Performance Advisors LLP purchased a new stake in shares of Colgate-Palmolive during the third quarter worth about $53,000. Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive during the third quarter valued at about $64,000. True Wealth Design LLC raised its position in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company's stock valued at $75,000 after purchasing an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC boosted its stake in Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company's stock worth $79,000 after purchasing an additional 368 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

NYSE CL traded up $0.23 during trading hours on Friday, reaching $88.79. The company's stock had a trading volume of 5,149,874 shares, compared to its average volume of 5,029,034. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The company's 50-day moving average is $92.27 and its two-hundred day moving average is $97.78. The firm has a market capitalization of $72.55 billion, a price-to-earnings ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.25%. Colgate-Palmolive's dividend payout ratio (DPR) is 57.31%.

Analyst Ratings Changes

A number of research analysts have issued reports on CL shares. TD Cowen decreased their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating for the company in a research note on Thursday. Stifel Nicolaus lowered their price target on Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating for the company in a research report on Friday. Piper Sandler cut their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a report on Monday, January 6th. Finally, Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $101.11.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.